J Pharmacoepidemiol Risk Manage.  2020 Sep;12(2):85-90.

Signal Detection of Rosuvastatin Calcium Using Spontaneous Adverse Drug Event Reports

Affiliations
  • 1Clinical Research Coordinating Center, The Catholic University of Korea, Bucheon, Korea
  • 2Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Bucheon, Korea
  • 3Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea
  • 4College of Pharmacy, The Catholic University of Korea, Bucheon, Korea

Abstract


Objective
The purpose of this study was to detect for the signals of rosuvastatin calcium applying a data mining analysis based on data of domestic adverse drug reaction reporting system and to check the detected signals listed in the drug label.
Methods
This study used the database based on drug-related side effects and adverse reactions, reported spontaneously to the Ministry of Food and Drug Safety (MFDS) through pharmacovigilance centers between Jul. 2009 and Dec. 2010. The database contains 46,231 reports of adverse drug events (ADEs) and 153,557 drug-adverse events (AEs) pairs reconstituted. Data mining analysis by proportional reporting ratio (PRR), reporting odds ratio (ROR), and information component (IC) conducted to detect signals of rosuvastatin calcium.
Results
The data which attributed to rosuvastatin calcium was 199 ADEs and 297 drug-AE pairs. There were 76 types of AEs in 297 drug-AE pairs. The AEs detected as signals of rosuvastatin calcium were 36 out of 76 AEs. The signals that did not include in the label of rosuvastatin calcium were 15 out of 36 signals (41.7%). Most of the unlabeled signals were AEs that rosuvastatin calcium reported as concomitant drugs. Unlabeled signals based on more than two drug-AE pairs were bradycardia, hyperkalemia, and azotemia.
Conclusion
The detected signals of rosuvastatin calcium were 36 reports. The detected signals not listed on the domestic and foreign drug labels were 41.7% among them, which was 19.7% of all reported types of rosuvastatin calcium adverse events.

Keyword

Adverse drug reaction reporting systems; Drug-related side effects and adverse reactions; Data mining; Rosuvastatin calcium; drug labeling
Full Text Links
  • JPERM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr